US Patent 8163284 Methods of treating TSLP-related inflammatory disorders
Patent 8163284 was granted and assigned to Amgen on April, 2012 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8163284 Methods of treating TSLP-related inflammatory disorders
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
